Date
Title
View
21 Jul 22
Vorläufiges Halbjahresergebnis zum 30. Juni 2022 und Prognoseänderung für das Geschäftsjahr 2022
View
21 Jun 22
Prognoseänderung für das Geschäftsjahr 2022
View
25 Feb 22
Preliminary annual results as of 31 December 2021
View
29 Nov 21
Change of forecast for the financial year 2021
View
13 Jul 21
Preliminary half-year results as of 30.06.2021
View
29 Apr 21
Application for change from Prime Standard to General Standard
View
18 Feb 21
KROMI takeover offer will not be pursued further
View
30 Dec 20
4basebio AG announces changes to the Management Board
View
05 Oct 20
4basebio announces share capital reduction by way of reverse stock split
View
24 Sep 20
4basebio AG signs term sheet for investment in nanoparticle-based gene therapy delivery technology
View
17 Aug 20
4basebio AG announces process for spin-off and separate stock market listing for its DNA business
View
20 Apr 20
4basebio AG: 4basebio AG resolves on capital reduction by way of redemption of approx. 5.2 million treasury shares in accordance with the authorizing resolution of the general meeting
View